D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
NVS holding history
Novartis AG in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −8,000−100.0% | Sold out | Holders |
| Q4 2025 | 8,000 | $1.10M | <0.1% | +3,294+70.0% | Added | Holders |
| Q3 2025 | 4,706 | $603.5K | <0.1% | −7,866−62.6% | Reduced | Holders |
| Q2 2025 | 12,572 | $1.52M | <0.1% | −23,380−65.0% | Reduced | Holders |
| Q1 2025 | 35,952 | $4.01M | <0.1% | −576,427−94.1% | Reduced | Holders |
| Q4 2024 | 612,379 | $59.6M | 0.1% | +563,955+1,164.6% | Added | Holders |
| Q3 2024 | 48,424 | $5.57M | <0.1% | +45,588+1,607.5% | Added | Holders |
| Q2 2024 | 2,836 | $301.9K | <0.1% | +2,836 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −54,817−100.0% | Sold out | Holders |
| Q4 2023 | 54,817 | $5.53M | <0.1% | −70,106−56.1% | Reduced | Holders |
| Q3 2023 | 124,923 | $12.7M | <0.1% | −142,019−53.2% | Reduced | Holders |
| Q2 2023 | 266,942 | $26.9M | <0.1% | +264,142+9,433.6% | Added | Holders |
| Q1 2023 | 2,800 | $257.6K | <0.1% | −20,643−88.1% | Reduced | Holders |
| Q4 2022 | 23,443 | $2.13M | <0.1% | +16,678+246.5% | Added | Holders |
| Q3 2022 | 6,765 | $514.0K | <0.1% | −236,647−97.2% | Reduced | Holders |
| Q2 2022 | 243,412 | $20.6M | <0.1% | −236,477−49.3% | Reduced | Holders |
| Q1 2022 | 479,889 | $42.1M | 0.1% | −1,340,015−73.6% | Reduced | Holders |
| Q4 2021 | 1,819,904 | $159.2M | 0.2% | +1,793,934+6,907.7% | Added | Holders |
| Q3 2021 | 25,970 | $2.12M | <0.1% | +15,329+144.1% | Added | Holders |
| Q2 2021 | 10,641 | $971.0K | <0.1% | +10,641 | New | Holders |